Immune Thrombocytopenia in Lymphoproliferative Disorders

Hematology/Oncology Clinics of North America

Volumn 23, Issue 6, 2009, Pages 1261-1274

  Visco, Carlo ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Chronic lymphocytic leukemia; Hodgkin lymphoma; Immune thrombocytopenia; ITP; Lymphoproliferative disorders; Non Hodgkin lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN; METHOTREXATE; PENTOSTATIN; RITUXIMAB; STEROID;

AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; B CELL LYMPHOMA; BLEEDING; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; HODGKIN DISEASE; HUMAN; INFECTION; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPLENECTOMY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; WALDENSTROEM MACROGLOBULINEMIA;

HUMANS; LYMPHOPROLIFERATIVE DISORDERS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 70449627917     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.08.006     Document Type: Review

References (98)

1. Rodeghiero F., Stasi R., Gernsheimer T., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113 11 (2009) 2386-2393
2. Hegde U.M., Zuiable A., Ball S., et al. The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: a clinical and serological evaluation in 508 patients. Clin Lab Haematol 7 1 (1985) 7-16
3. Liebman H. Other immune thrombocytopenias. Semin Hematol 44 4 Suppl 5 (2007) S24-S34
4. Dührsen U., Augener W., Zwingers T., et al. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol 67 2 (1987) 235-239
5. Hamblin T.J., Oscier D.G., and Young B.J. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 39 7 (1986) 713-716
6. Kyasa M.J., Parrish R.S., Schichman S.A., et al. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 74 1 (2003) 1-8
7. Diehl L.F., and Ketchum L.H. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25 1 (1998) 80-97
8. Visco C., Ruggeri M., Laura Evangelista M., et al. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood 111 3 (2008) 1110-1116
9. Hauswirth A.W., Skrabs C., Schützinger C., et al. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas. Haematologica 93 3 (2008) 447-450
10. Váróczy L., Gergely L., Zeher M., et al. Malignant lymphoma-associated autoimmune diseases: a descriptive epidemiological study. Rheumatol Int 22 6 (2002) 233-237
11. Jones S.E. Autoimmune disorders and malignant lymphoma. Cancer 31 5 (1973) 1092-1098
12. Grønbaek K., D'Amore F., and Schmidt K. Autoimmune phenomena in non-Hodgkin's lymphoma. Leuk Lymphoma 18 3-4 (1995) 311-316
13. Bradley S.J., Hudson G.V., and Linch D.C. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a report of eight cases. Clin Oncol (R Coll Radiol) 5 6 (1993) 355-357
14. Xiros N., Binder T., Anger B., et al. Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease. Eur J Haematol 40 5 (1988) 437-441
15. Kelton J.G., Murphy W.G., Lucarelli A., et al. A prospective comparison of four techniques for measuring platelet-associated IgG. Br J Haematol 71 1 (1989) 97-105
16. Warner M.N., Moore J.C., Warkentin T.E., et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol 104 3 (1999) 442-447
17. Hamblin T.J. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 33 2 (2006) 230-239
18. Hallek M., Cheson B.D., Catovsky D., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111 12 (2008) 5446-5456
19. Leach M., Parsons R.M., Reilly J.T., et al. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders. Clin Lab Haematol 22 3 (2000) 175-178
20. Otton S.H., Turner D.L., Frewin R., et al. Autoimmune thrombocytopenia after treatment with Campath 1H in a patient with chronic lymphocytic leukaemia. Br J Haematol 106 1 (1999) 261-262
21. Visco C., Giaretta I., Ruggeri M., et al. Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia 21 5 (2007) 1092-1093
22. Mockridge C.I., Potter K.N., Wheatley I., et al. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood 109 10 (2007) 4424-4431
23. Visco C., Giaretta I., Ruggeri M., et al. Rai and Binet classifications for chronic lymphocytic leukemia should recognize a role for immune thrombocytopenia, but not for autoimmune haemolytic anemia. Haematologica 93 s1 (2008) 36
24. Hervé M., Xu K., Ng Y.S., et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 115 6 (2005) 1636-1643
25. Tobin G., Thunberg U., Karlsson K., et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104 9 (2004) 2879-2885
26. Messmer B.T., Albesiano E., Efremov D.G., et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200 4 (2004) 519-525
27. Barcellini W., Capalbo S., Agostinelli R.M., et al. GIMEMA Chronic Lymphocytic Leukemia Group. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica 91 12 (2006) 1689-1692
28. Rubinstein D.B., and Longo D.L. Peripheral destruction of platelets in chronic lymphocytic leukemia: recognition, prognosis and therapeutic implications. Am J Med 71 4 (1981) 729-732
29. Kaden B.R., Rosse W.F., and Hauch T.W. Immune thrombocytopenia in lymphoproliferative diseases. Blood 53 4 (1979) 545-551
30. Ebbe S., Wittels B., and Dameshek W. Autoimmune thrombocytopenic purpura (ITP type) with chronic lymphocytic leukemia. Blood 19 (1962) 23-37
31. Cortes J., O'Brien S., Loscertales J., et al. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. Cancer 92 8 (2001) 2016-2022
32. Carey R.W., McGinnis A., Jacobson B.M., et al. Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia. Arch Intern Med 136 1 (1976) 62-66
33. Aghai E., Quitt M., Lurie M., et al. Primary hepatic lymphoma presenting as symptomatic immune thrombocytopenic purpura. Cancer 60 9 (1987) 2308-2311
34. Hegde U.P., Wilson W.H., White T., et al. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. Blood 100 6 (2002) 2260-2262
35. Zaja F., Vianelli N., Sperotto A., et al. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma 44 11 (2003) 1951-1955
36. Ammatuna E., Marino C., Mitra M.E., et al. Successful treatment of steroid resistant autoimmune thrombocytopenia associated with chronic lymphocytic leukemia with alemtuzumab. Eur J Haematol 73 3 (2004) 225-226
37. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 13 (2002) 995-1008
38. Portielje J.E., Westendorp R.G., Kluin-Nelemans H.C., et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97 9 (2001) 2549-2554
39. Fernandez M.J., Llopis I., Pastor E., et al. Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. Haematologica 88 2 (2003) ELT02
40. Provan D., Butler T., Evangelista M.L., et al. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica 92 12 (2007) 1695-1698
41. Carson K.R., Evens A.M., Richey E.A., et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113 20 (2009) 4834-4840
42. Jønsson V., Kierkegaard A., Salling S., et al. Autoimmunity in Waldenström's macroglobulinaemia. Leuk Lymphoma 34 3-4 (1999) 373-379
43. Owen R.G., Lubenko A., Savage J., et al. Autoimmune thrombocytopenia in Waldenström's macroglobulinemia. Am J Hematol 66 2 (2001) 116-119
44. Stone M.J., Merlini G., and Pascual V. Autoantibody activity in Waldenstrom's macroglobulinemia. Clin Lymphoma 5 4 (2005) 225-229
45. Varticovski L., Pick A.I., Schattner A., et al. Anti-platelet and anti-DNA IgM in Waldenström macroglobulinemia and ITP. Am J Hematol 24 4 (1987) 351-355
46. Lehman H.A., Lehman L.O., Rustagi P.K., et al. Complement-mediated autoimmune thrombocytopenia: monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease. N Engl J Med 316 4 (1987) 194-198
47. Patel T.C., Moore S.B., Pineda A.A., et al. Role of plasmapheresis in thrombocytopenic purpura associated with Waldenström's macroglobulinemia. Mayo Clin Proc 71 6 (1996) 597-600
48. Verdirame J.D., Feagler J.R., and Commers J.R. Multiple myeloma associated with immune thrombocytopenic purpura. Cancer 56 5 (1985) 1199-1200
49. Gupta V., Hegde U.M., Parameswaran R., et al. Multiple myeloma and immune thrombocytopenia. Clin Lab Haematol 22 4 (2000) 239-242
50. Falco P., Bertola A., Bringhen S., et al. Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma. Hematol J 5 5 (2004) 456-457
51. Rossi D., De Paoli L., Franceschetti S., et al. Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance. Br J Haematol 138 2 (2007) 249-252
52. Kuwana M., Iki S., and Urabe A. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab. Am J Hematol 82 9 (2007) 846-848
53. Fritz E., Ludwig H., Scheithauer W., et al. Shortened platelet half-life in multiple myeloma. Blood 68 2 (1986) 514-520
54. McGrath K.M., Stuart J.J., and Richards II F. Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states. Br J Haematol 42 4 (1979) 585-591
55. Thieblemont C., Felman P., Callet-Bauchu E., et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 4 2 (2003) 95-103
56. Magagnoli M., Balzarotti M., Castagna L., et al. Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?. Leuk Lymphoma 44 9 (2003) 1639-1640
57. Sakalli H., Akcali Z., Kayaselcuk F., et al. MALTOMA presenting with thrombocytopenia. Am J Clin Oncol 28 3 (2005) 321-322
58. Bachmeyer C., Audouin J., Bouillot J.L., et al. Immune thrombocytopenic purpura as the presenting feature of gastric MALT lymphoma. Am J Gastroenterol 95 6 (2000) 1599-1600
59. Figueroa M., Gehlsen J., Hammond D., et al. Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med 328 17 (1993) 1226-1229
60. Baudard M., Comte F., Conge A.M., et al. Importance of [18F] fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma. Leuk Lymphoma 48 2 (2007) 381-388
61. Kawashima T., Nishimura H., Akiyama H., et al. Primary pulmonary mucosa-associated lymphoid tissue lymphoma combined with idiopathic thrombocytopenic purpura and amyloidoma in the lung. J Nippon Med Sch 72 6 (2005) 370-374
62. Noda M., Mori N., Nomura K., et al. Regression of idiopathic thrombocytopenic purpura after endoscopic mucosal resection of gastric mucosa associated lymphoid tissue lymphoma. Gut 53 11 (2004) 1698-1700
63. Murakami H., Irisawa H., Saitoh T., et al. Immunological abnormalities in splenic marginal zone cell lymphoma. Am J Hematol 56 3 (1997) 173-178
64. Nakagawa H. A case of primary cardiac lymphoma complicated by idiopathic thrombocytopenic purpura. Nihon Kokyuki Gakkai Zasshi 40 3 (2002) 265-269 [in Japanese]
65. Tadokoro J., Gunji H., Handa T., et al. Primary renal non-Hodgkin's lymphoma presenting as immune thrombocytopenia. Rinsho Ketsueki 42 1 (2001) 41-46 [in Japanese]
66. Moriwaki Y., Naka M., Yamamoto T., et al. Malignant lymphoma in the mesentery with immune thrombocytopenia. Intern Med 31 10 (1992) 1185-1189
67. Hequet O., Salles G., Ketterer N., et al. Autoimmune thrombocytopenic purpura after autologous stem cell transplantation. Bone Marrow Transplant 32 1 (2003) 89-95
68. Ashihara E., Shimazaki C., Hirata T., et al. Autoimmune thrombocytopenia following peripheral blood stem cell autografting. Bone Marrow Transplant 12 3 (1993) 297-299
69. Hensel M., and Ho A.D. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab. Am J Hematol 73 1 (2003) 37-40
70. Virchis A.E., Jan-Mohamed R., Kaczmarski K.S., et al. Primary splenic hairy cell leukaemia variant presenting as immune thrombocytopenic purpura. Eur J Haematol 61 4 (1998) 288-291
71. Kawachi Y., Ide M., Uchida T., et al. Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab. Rinsho Ketsueki 44 1 (2003) 31-33 [in Japanese]
72. Otrock Z.K., Mahfouz R.A., Oghlakian G.O., et al. Rituximab-induced acute thrombocytopenia: a report of two cases. Haematologica 90 Suppl (2005) ECR23
73. Dhand S., and Bahrain H. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature. Cancer Invest 26 9 (2008) 913-915
74. Ram R., Bonstein L., Gafter-Gvili A., et al. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. Am J Hematol 84 4 (2009) 247-250
75. Thachil J., Mukherje K., and Woodcock B. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia. Br J Haematol 135 2 (2006) 273-274
76. Shah C., and Grethlein S.J. Case report of rituximab-induced thrombocytopenia. Am J Hematol 75 4 (2004) 263
77. Rigamonti C., Volta C., Colombi S., et al. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Leukemia 15 1 (2001) 186-187
78. Motta G., Vianello F., Menin C., et al. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome). Am J Hematol 69 4 (2002) 272-276
79. Yao M., Tien H.F., Lin M.T., et al. Clinical and hematological characteristics of hepatosplenic T gamma/delta lymphoma with isochromosome for long arm of chromosome 7. Leuk Lymphoma 22 5-6 (1996) 495-500
80. Lin M.T., Shen M.C., Su I.J., et al. Peripheral T gamma/delta lymphoma presenting with idiopathic thrombocytopenic purpura-like picture. Br J Haematol 78 2 (1991) 280-282
81. Suehiro S., Shiratsuchi M., Suehiro Y., et al. Angioimmunoblastic T cell lymphoma (AITL) with autoimmune thrombocytopenia. Rinsho Ketsueki 43 9 (2002) 841-845 [in Japanese]
82. Garderet L., Aoudjhane M., Bonte H., et al. Immune thrombocytopenic purpura: first symptom of gamma/delta T -cell lymphoma. Am J Med 111 3 (2001) 242-243
83. Dhodapkar M.V., Li C.Y., Lust J.A., et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 84 5 (1994) 1620-1627
84. Gentile T.C., Wener M.H., Starkebaum G., et al. Humoral immune abnormalities in T-cell large granular lymphocyte leukemia. Leuk Lymphoma 23 3-4 (1996) 365-370
85. Lamy T., and Loughran Jr. T.P. Current concepts: large granular lymphocyte leukemia. Blood Rev 13 4 (1999) 230-240
86. Rose M.G., and Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 9 3 (2004) 247-258
87. Martinelli G., Zinzani P.L., Magagnoli M., et al. Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission. Haematologica 83 7 (1998) 669-670
88. Tahiliani R.R., Banavali S.D., Parikh P.M., et al. Idiopathic thrombocytopaenic purpura in patients during remission of Hodgkin's disease. J Assoc Physicians India 37 2 (1989) 141-143
89. Kedar A., Khan A.B., Mattern J.Q., et al. Autoimmune disorders complicating adolescent Hodgkin's disease. Cancer 44 1 (1979) 112-116
90. Waddell C.C., and Cimo P.L. Idiopathic thrombocytopenic purpura occurring in Hodgkin disease after splenectomy: report of two cases and review of the literature. Am J Hematol 7 4 (1979) 381-387
91. Cohen J.R. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a rare occurrence of no prognostic significance. Cancer 41 2 (1978) 743-746
92. Murphy W.G., Allan N.C., Perry D.J., et al. Hodgkin's disease presenting as idiopathic thrombocytopenic purpura. Postgrad Med J 60 707 (1984) 614-615
93. Pedro-Botet J., Estruch R., Montserrat E., et al. Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin's disease. Scand J Haematol 36 4 (1986) 408-410
94. Ertem M., Uysal Z., Yavuz G., et al. Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease. Pediatr Hematol Oncol 17 2 (2000) 181-185
95. Cines D.B., Bussel J.B., Liebman H.A., et al. The ITP syndrome: pathogenic and clinical diversity. Blood 113 26 (2009) 6511-6521
96. Mittal S., Blaylock M.G., Culligan D.J., et al. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura. Haematologica 93 1 (2008) 151-152
97. Anaissie E.J., Kontoyiannis D.P., O'Brien S., et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 129 7 (1998) 559-566
98. Wei S., Kryczek I., and Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 108 2 (2006) 426-431